Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FAME study will evaluate effects of lipid lowering in the elderly

Nov. 10, 1998

Sanguine reports significant breakthrough in the development of blood substitute

Nov. 9, 1998

Droloxifene effects on lipid parameters evaluated in healthy postmenopausal women

Nov. 9, 1998

Oral antioxidant improves endothelial function in diabetic men

Nov. 9, 1998

Avasimibe a protagonist at the AHA's 71st scientific sessions

Nov. 9, 1998

KW-8232 prevents bone loss and inhibits bone resorption in animal model of osteopenia

Nov. 6, 1998

Pfizer and Hoechst Marion Roussel reach agreement for worldwide development of inhaled insulin

Nov. 5, 1998

Lipid-lowering ACAT inhibitors claimed in patent literature by Yakult Honsha

Nov. 5, 1998

Schering-Plough describes SAR leading to discovery of potent cholesterol absorption inhibitor

Nov. 4, 1998

Hisamitsu, Banyu codevelop new hypolipidemic agent entering phase II

Nov. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...